JACC This Week
By American College of Cardiology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by American College of Cardiology
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 106
Reviews: 0
Episodes: 729
Description
Weekly summary and focused insights of the high-impact cardiovascular research published in the JACC from Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, shaping cardiovascular care today.
| Episode | Date |
|---|---|
|
November 4, 2025: The 2025 Hypertension Guideline: A New Era in Blood Pressure Control | JACC This Week
|
Oct 28, 2025 |
|
October 28.2025: How Low Should We Go? | JACC This Week
|
Oct 20, 2025 |
|
October 21, 2025 - The Adipokine Hypothesis, Adipose-Cardiac Signaling, Sex Differences, Therapeutic Implications, and Diverse Populations | JACC This Week
|
Oct 13, 2025 |
|
October 14, 2025 - Emerging Frontiers in Cardiovascular Medicine: From Certification Reform to Inflammation Targeting | JACC This Week
|
Oct 06, 2025 |
|
Computable Quality, Community Screening, and TAVR Debate | JACC This Week
|
Sep 29, 2025 |
|
AI, Polygenic Risk Scores, and Antithrombotic Therapy | JACC This Week
|
Sep 15, 2025 |
|
Reframing Cardiovascular Care | JACC This Week
|
Sep 08, 2025 |
|
Heart Failure Insights, AI Standards, and Genetic Clues | JACC This Week
|
Sep 03, 2025 |
|
Cognitive Risk in CHD and Cardiology Practice Meets Lifestyle Realities | JACC This Week
|
Aug 25, 2025 |
|
Pacing Strategies, Air Quality, and the Path to Equity | JACC This Week
|
Aug 18, 2025 |
|
Device Safety, DAPT Strategy & Structural Innovation | JACC This Week
|
Aug 11, 2025 |
|
Amyloidosis in Focus: Biomarkers, Structural Insights & Therapeutic Strategy | JACC This Week
|
Aug 04, 2025 |
|
Out-of-Hospital Cardiac Arrest in Septuagenarians, Octogenarians, and Nonagenarians in Japan: Trends and Patterns in Outcomes | JACC Baran
|
Jul 29, 2025 |
|
Zeroing In on Prevention: ARIC and the Future of Cardiovascular Risk | JACC Baran
|
Jul 29, 2025 |
|
Epidemiology and Outcomes in HFimpEF | JACC Deep Dive
|
Jul 28, 2025 |
|
Heart Failure in Practice: Dual Therapy Insights, Digital Innovation & the Future of Risk Models | JACC This Week
|
Jul 28, 2025 |
|
JACC Editor's Page: June 30, 2025 | JACC
|
Jul 21, 2025 |
|
JACC Editor's Page: July 7. 2025 | JACC
|
Jul 21, 2025 |
|
IHCA Incidence Rates | JACC Deep Dive
|
Jul 21, 2025 |
|
Plaque Vulnerability and Risk Factors | JACC Deep Dive
|
Jul 21, 2025 |
|
Validation of AHA PREVENT in Healthcare Populations | JACC Deep Dive
|
Jul 21, 2025 |
|
ACURATE neo2 Under-Expansion | JACC Deep Dive
|
Jul 21, 2025 |
|
Structural Heart Disease, Obesity-Related Heart Failure, Private Equity Ownership in Hospitals | JACC This Week
|
Jul 21, 2025 |
|
Prevention in Focus: Polypill Projections, Risk Equations & Global Syndemic Trends | JACC This Week
|
Jul 14, 2025 |
|
Cardiovascular Interventions in Focus: Plaque Vulnerability, PCI Outcomes & Outpatient Cardiac Care Trends | JACC This Week
|
Jul 07, 2025 |
|
Electrophysiology in Focus: AFIB Management, LAA Closure Insights and Stroke Risk Strategies | JACC This Week
|
Jun 30, 2025 |
|
Podcasts at JACC: Past and Future | JACC This Week
|
Jun 23, 2025 |
|
JACC Editor's Page: June 23, 2025 | JACC
|
Jun 23, 2025 |
|
Wildfire-Linked Heart Failure, Impella Trial Insights, Cognitive Impairment in CVD & New Mortality Data | JACC This Week
|
Jun 23, 2025 |
|
JACC Editor's Page: June 16, 2025
|
Jun 17, 2025 |
|
Long-term Survival and Patient Reported Outcomes after Staged Reconstructive Surgery for Hypoplastic Left Heart Syndrome | JACC
|
Jun 16, 2025 |
|
Relationship between exercise-induced cardiac troponin elevations and occult coronary atherosclerosis in middle-aged athletes | JACC
|
Jun 16, 2025 |
|
Differences in Arterial Events in Ehlers-Danlos, Loeys-Dietz, and Marfan Syndrome | JACC
|
Jun 16, 2025 |
|
Characterization of Arterial Aneurysms in Loeys-Dietz Syndrome | JACC
|
Jun 16, 2025 |
|
June 24, 2025 Issue Summary | JACC
|
Jun 16, 2025 |
|
Sleep and Heart Failure: LV Function Findings from the ADVENT-HF Trial | JACC Baran
|
Jun 10, 2025 |
|
JACC Editor's Page: June 9, 2025
|
Jun 09, 2025 |
|
Long-acting Factor XI Inhibition and Peri-procedural Bleeding: An Analysis from AZALEA-TIMI 71 | JACC
|
Jun 09, 2025 |
|
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective Registry | JACC
|
Jun 09, 2025 |
|
Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12 | JACC
|
Jun 09, 2025 |
|
10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population | JACC
|
Jun 09, 2025 |
|
June 17, 2025 Issue Summary | JACC
|
Jun 09, 2025 |
|
ACS Guidelines | A Latin American Perspective | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | Closer to a Universal Document | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | Maturation of Lipid Management | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | A Holistic View | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | Gaps Within Evidence Gaps | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | A Personal Perspective | JACC
|
Jun 03, 2025 |
|
ACS Guidelines | MCS in Acute Myocardial Infarction-Cardiogenic Shock | JACC
|
Jun 03, 2025 |
|
Chronic Stent Recoil: A Hidden Cost of Thinner Struts? | JACC Baran
|
Jun 03, 2025 |
|
June 10, 2025 Issue Summary | JACC
|
Jun 02, 2025 |
|
Acoramidis and Early sTTR Rise: Biomarker-Driven Insights into Survival | JACC Baran
|
May 27, 2025 |
|
June 3, 2025 Issue Summary | JACC
|
May 27, 2025 |
|
Insights From the INTERASPIRE Study | JACC Deep Dive
|
May 27, 2025 |
|
SORT OUT XI | EuroPCR.25 | JACC
|
May 21, 2025 |
|
VT Prevention in Repaired Tetralogy of Fallot: Mapping SCAI and Minimizing ICDs | JACC Baran
|
May 20, 2025 |
|
Vutrisiran Impact on Functional Capacity and QOL | JACC Deep Dive | JACC
|
May 20, 2025 |
|
10 Year Outcome of DANAMI 3 PRIMULTI | JACC | EuroPCR.25 | JACC
|
May 19, 2025 |
|
May 27, 2025 Issue Summary | JACC
|
May 19, 2025 |
|
Vutrisiran and Mortality in ATTR-CM | JACC | ESCHF25
|
May 17, 2025 |
|
Rethinking Rehab: ACTIVE-ADHF and the Power of Early Intervention | JACC Baran
|
May 13, 2025 |
|
Individual Variation in Tirzepatide Response | JACC Deep Dive
|
May 13, 2025 |
|
JACC Editor's Page: March 18, 2025 | JACC
|
May 12, 2025 |
|
May 20, 2025 Issue Summary | JACC
|
May 12, 2025 |
|
Altshock-2 Through a Regional Lens: IABP in HF-CS | JACC Baran
|
May 06, 2025 |
|
Revisiting the SUMMIT Trial | JACC Deep Dive
|
May 06, 2025 |
|
Disentangling the Impact of Adiposity From Insulin Resistance in HFpEF | JACC Deep Dive
|
May 06, 2025 |
|
Anthracycline Cardiotoxicity in Adult Cancer Patients: JACC: CardioOncology State-of-the-Art Review | JACC
|
May 05, 2025 |
|
Disentangling the Impact of Adiposity From Insulin Resistance in Heart Failure with Preserved Ejection Fraction | JACC
|
May 05, 2025 |
|
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: the EMPEROR Program | JACC
|
May 05, 2025 |
|
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction and Obesity: the SUMMIT Trial | JACC
|
May 05, 2025 |
|
May 13, 2025 Issue Summary | JACC
|
May 05, 2025 |
|
Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results from ORBITA-2 | JACC
|
May 05, 2025 |
|
JACC Editor's Page: May 13, 2025
|
May 05, 2025 |
|
Aortic Stenosis Under Pressure: Decoding Low-Gradient Risk Profiles | JACC Baran
|
Apr 29, 2025 |
|
1-Year Results of ADVANTAGE AF | JACC Deep Dive
|
Apr 29, 2025 |
|
Sudden Cardiac Arrest in Young Athletes | JACC Deep Dive
|
Apr 29, 2025 |
|
JACC Editor's Page: May 6, 2025 | JACC
|
Apr 28, 2025 |
|
State of the Art: Mapping Strategies to Guide Ablation in Ischemic Heart Disease | JACC
|
Apr 28, 2025 |
|
Proactive mapping and preventive ablation reduce defibrillator implantation rates in Tetralogy of Fallot | JACC
|
Apr 28, 2025 |
|
Survival Outcomes after Sudden Cardiac Arrest in Young Competitive Athletes from the United States | JACC
|
Apr 28, 2025 |
|
Pulse Field Ablation for Persistent Atrial Fibrillation: One-Year Results of ADVANTAGE AF | JACC
|
Apr 28, 2025 |
|
Finerenone Reduces New-Onset Atrial Fibrillation across the Spectrum of Cardio-Kidney-Metabolism: the FINE-HEART Pooled Analysis | JACC
|
Apr 28, 2025 |
|
Advancing Electrophysiology: Innovations, Challenges, and the Future of Arrhythmia Management | JACC
|
Apr 28, 2025 |
|
May 6, 2025 Issue Summary | JACC
|
Apr 28, 2025 |
|
Bridging Gaps for SCD Prevention in HCM: Why Regional Validation Matters | JACC Baran
|
Apr 22, 2025 |
|
Altshock-2 | JACC Deep Dive
|
Apr 21, 2025 |
|
JACC Editor's Page: April 29, 2025 | JACC
|
Apr 21, 2025 |
|
Mixed Cardiogenic-Vasodilatory Shock: Current Insights and Future Directions | JACC
|
Apr 21, 2025 |
|
A Vascular Plug for Persistent Shock Following Transcatheter Mitral Valve Replacement | JACC
|
Apr 21, 2025 |
|
LAVA-ECMO–Supported Dual-Transcatheter Aortic and Mitral Valve-in-Valve Replacement in Cardiogenic Shock | JACC
|
Apr 21, 2025 |
|
Nonhemorrhagic Pericardial Effusion With Tamponade and Cardiogenic Shock Due to Large Coronary Artery Fistula | JACC
|
Apr 21, 2025 |
|
Single-Access Technique for Impella-Assisted Balloon Aortic Valvuloplasty and High-Risk PCI in Cardiogenic Shock | JACC
|
Apr 21, 2025 |
|
The Influence of Extracorporeal Life Support on Patients in Cardiogenic Shock Assessed by Machine Learning: A Machine Learning Subanalysis From the ECLS-SHOCK Trial | JACC
|
Apr 21, 2025 |
|
2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock | JACC
|
Apr 21, 2025 |
|
Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial | JACC
|
Apr 21, 2025 |
|
Advancing Care in Cardiogenic Shock: Evidence, Innovation, and Commitment | JACC
|
Apr 21, 2025 |
|
April 29, 2025 Issue Summary | JACC
|
Apr 21, 2025 |
|
From Hokkaido to ACC: NT-proBNP Screening for Pre-Heart Failure in Rural Japan | JACC Baran
|
Apr 15, 2025 |
|
JACC Editor's Page: April 22, 2025 | JACC
|
Apr 14, 2025 |
|
Conduction Disturbances After Transcatheter Aortic Valve Replacement: An Update on Epidemiology, Preventive Strategies, and Management | JACC
|
Apr 14, 2025 |
|
Impact of Catheter Ablation of Atrial Fibrillation on Disease Progression | JACC
|
Apr 14, 2025 |
|
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry | JACC
|
Apr 14, 2025 |
|
Pre-Pregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife | JACC
|
Apr 14, 2025 |
|
5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis | JACC
|
Apr 14, 2025 |
|
April 22, 2025 Issue Summary | JACC
|
Apr 14, 2025 |
|
Troponin in Translation: The 0/1-Hour Algorithm Across Asia | JACC Baran
|
Apr 08, 2025 |
|
JACC Editor's Page: April 15, 2025 | JACC
|
Apr 07, 2025 |
|
Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Individuals | JACC
|
Apr 07, 2025 |
|
Cardiac Troponins and Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis | JACC
|
Apr 07, 2025 |
|
April 15, 2025 Issue Summary | JACC
|
Apr 07, 2025 |
|
Small Molecule PCSK9 Inhibitor for Hypercholesterolemia | JACC | ACC.25
|
Apr 01, 2025 |
|
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies | JACC | ACC.25
|
Apr 01, 2025 |
|
Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock | JACC | ACC.25
|
Apr 01, 2025 |
|
Individual Variation in Tirzepatide Response | JACC | ACC.25
|
Apr 01, 2025 |
|
Survival After Sudden Cardiac Arrest in Athletes | JACC | ACC.25
|
Apr 01, 2025 |
|
Self-Expanding Valve Outcomes at 5 Years Compared to Surgery | JACC | ACC.25
|
Apr 01, 2025 |
|
Gold Cards & Hidden Triggers: A New Look at Afib | JACC Baran
|
Apr 01, 2025 |
|
The Cardiovascular Care of the Pediatric Athlete | JACC
|
Mar 31, 2025 |
|
Impact of Transcather or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥Intermediate Risk | JACC
|
Mar 31, 2025 |
|
Nonlinear Relation between Cardiac Mortality and Excess Temperature in Heatwaves: Exposure Response in 2.39 Million Patients | JACC
|
Mar 31, 2025 |
|
New Threshold for Defining Mild Aortic Stenosis Derived from Velocity-Encoded MRI in 60,000 Individuals | JACC
|
Mar 31, 2025 |
|
April 8, 2025 Issue Summary | JACC
|
Mar 31, 2025 |
|
Incident Atrial Fibrillation in FINE-HEART | JACC | ACC.25
|
Mar 27, 2025 |
|
Use of Cardiac Rehab in Older Patients with MI Complicated by Cardiogenic Shock | JACC | ACC.25
|
Mar 25, 2025 |
|
Effect of plozasiran on lipoprotein particles by NMR | JACC | ACC.25
|
Mar 25, 2025 |
|
Exploring High-Gradient Aortic Stenosis | JACC Baran
|
Mar 25, 2025 |
|
Vutrisiran Efficacy by Baseline ATTR-CM Severity | JACC | ACC.25
|
Mar 24, 2025 |
|
Elevated remnant cholesterol contributes to the risk of peripheral artery disease: a Mendelian randomization study | JACC
|
Mar 24, 2025 |
|
Invasive versus Conservative Management of Patients with Chronic Total Occlusion: Results From the ISCHEMIA Trial | JACC
|
Mar 24, 2025 |
|
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial | JACC
|
Mar 24, 2025 |
|
Ensemble Deep Learning Algorithm for Structural Heart Disease Screening Using Electrocardiographic Images: PRESENT SHD | JACC
|
Mar 24, 2025 |
|
Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients 40-75 Years | JACC
|
Mar 24, 2025 |
|
April 1, 2025 Issue Summary | JACC
|
Mar 24, 2025 |
|
Use of Cardiac Rehab in Older Patients with MI Complicated by Cardiogenic Shock | JACC | ACC.25
|
Mar 24, 2025 |
|
Federal Funding Cuts & Aortic Valve Replacement Outcomes | JACC Baran
|
Mar 18, 2025 |
|
A New Era in Electrophysiology: Innovation, Integration, and Impact | JACC
|
Mar 17, 2025 |
|
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-analysis of Randomized Trials | JACC
|
Mar 17, 2025 |
|
In the Wake of OCEANIC-AF is Factor XI inhibition Lost at Sea or Still Afloat? | JACC
|
Mar 17, 2025 |
|
In CASTLE-HTx Trial We Trust | JACC
|
Mar 17, 2025 |
|
Biomarker-based model for prediction of ischemic stroke in patients with atrial fibrillation | JACC
|
Mar 17, 2025 |
|
Antithrombotic Therapy to Minimize Total Events after ACS or PCI in Atrial Fibrillation: Insights from AUGUSTUS | JACC
|
Mar 17, 2025 |
|
Five-Year Results from the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | JACC
|
Mar 17, 2025 |
|
Can ICD Electrograms help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial | JACC
|
Mar 17, 2025 |
|
Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers | JACC
|
Mar 17, 2025 |
|
March 25, 2025 Issue Summary | JACC
|
Mar 17, 2025 |
|
JACC Editor's Page: March 25, 2025 | JACC
|
Mar 17, 2025 |
|
Systolic BP & CV Mortality in US Adults Aged 80+ Taking Antihypertensive Medications| JACC | ACC.25
|
Mar 17, 2025 |
|
RSV and Incidence of Cardiovascular Events | JACC | ACC.25 | JACC
|
Mar 17, 2025 |
|
Cognitive Function and Patient-Reported Outcomes after Cardiogenic Shock | JACC | ACC.25
|
Mar 17, 2025 |
|
Managing Cardiogenic Shock Caused by Acute MI | JACC | ACC.25
|
Mar 17, 2025 |
|
Skype and Diaphragm Ultrasound in Heart Failure | JACC Baran
|
Mar 11, 2025 |
|
JACC Editor's Page: March 18, 2025 | JACC
|
Mar 10, 2025 |
|
Clinical Considerations for Q1 Competitive Sports Participation for Athletes With Cardiovascular Abnormalities | JACC
|
Mar 10, 2025 |
|
Best Practices for Imaging of Transcatheter Valve Failure: An Update from the Heart Valve Collaboratory | JACC
|
Mar 10, 2025 |
|
Association between cigarette smoking and subclinical markers of cardiovascular harm | JACC
|
Mar 10, 2025 |
|
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy | JACC
|
Mar 10, 2025 |
|
Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases : A 14-Year Retrospective Study | JACC
|
Mar 10, 2025 |
|
Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure | JACC
|
Mar 10, 2025 |
|
March 18, 2025 Issue Summary | JACC
|
Mar 10, 2025 |
|
Diagnostic Performance and Clinical Impact of Photon-Counting Detector CT in CAD | JACC Baran
|
Mar 04, 2025 |
|
Advancing Transcatheter Aortic Valve Replacement: Expanding Evidence, Refining Strategies | JACC: Inside This Issue
|
Mar 03, 2025 |
|
Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art Review | JACC
|
Mar 03, 2025 |
|
Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials | JACC
|
Mar 03, 2025 |
|
Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis | JACC
|
Mar 03, 2025 |
|
Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries | JACC
|
Mar 03, 2025 |
|
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD | JACC
|
Mar 03, 2025 |
|
The Evolving Landscape of TAVR: A JACC Themed Issue | JACC
|
Mar 03, 2025 |
|
March 11, 2025 Issue Summary | JACC
|
Mar 03, 2025 |
|
P2Y12 Inhibitor Pretreatment in Non–ST-Segment Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry | JACC Baran
|
Feb 25, 2025 |
|
The Essential Role of Cardiovascular Surgery in Cardiology - JACC
|
Feb 24, 2025 |
|
Domino Heart Valve Transplant in Children With Congenital Valve Disease: Short-Term Outcomes, Growth, and Immunosensitization | JACC
|
Feb 24, 2025 |
|
Outcomes for Children With Congenital Heart Disease Undergoing Ventricular Assist Device Implantation: An ACTION Registry Analysis | JACC
|
Feb 24, 2025 |
|
Long-Term Outcomes of Contemporary Surgical Repair for Degenerative Mitral Regurgitation | JACC
|
Feb 24, 2025 |
|
The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial | JACC
|
Feb 24, 2025 |
|
Days Alive Out of Health Care: A Novel Measure of Health Status After Congenital Heart Surgery | JACC
|
Feb 24, 2025 |
|
The Nonsyndromic Ascending Thoracic Aorta in a Population-Based Setting: A 5-Year Prospective Cohort Study | JACC
|
Feb 24, 2025 |
|
The Essential Role of Cardiovascular Surgery in Cardiology: A Perspective From JACC | JACC
|
Feb 24, 2025 |
|
Introducing JACC-Baran & FINEARTS-HF Renal Function | JACC Baran
|
Feb 18, 2025 |
|
The Super Bowl & HCM Proteomics | JACC Baran
|
Feb 18, 2025 |
|
Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARC
|
Feb 17, 2025 |
|
JACC - Preprints: A Revolution in Cardiovascular Science
|
Feb 10, 2025 |
|
2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke: A Report of the American College of Cardiology Solution Set Oversight Committee
|
Feb 10, 2025 |
|
Management of Coronary Stent Underexpansion
|
Feb 10, 2025 |
|
Associations of Short-Term Ozone Exposure With Hypoxia and Arterial Stiffness
|
Feb 10, 2025 |
|
Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump: Is it DANGERous?
|
Feb 10, 2025 |
|
Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study
|
Feb 10, 2025 |
|
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial
|
Feb 10, 2025 |
|
JACC - February 18, 2025 Issue Summary
|
Feb 10, 2025 |
|
Navigating the 2024 ESC Hypertension Guidelines: What Is New, Context, and Future Directions
|
Feb 03, 2025 |
|
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial
|
Feb 03, 2025 |
|
Incidental and Progressive Tobacco Smoking in Childhood and Subsequent Risk of Premature Cardiac Damage
|
Feb 03, 2025 |
|
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
|
Feb 03, 2025 |
|
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry)
|
Feb 03, 2025 |
|
Social Determinants of Health, Cardiovascular Health, and Mortality in Sexual Minority Individuals in the United States
|
Feb 03, 2025 |
|
Long-Term Lipid Lowering With Evolocumab in Older Individuals
|
Feb 03, 2025 |
|
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study
|
Feb 03, 2025 |
|
Accelerometer-Measured Sedentary Behavior and Risk of Future Cardiovascular Disease
|
Feb 03, 2025 |
|
Higher Aircraft Noise Exposure Is Linked to Worse Heart Structure and Function by Cardiovascular MRI
|
Feb 03, 2025 |
|
Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study
|
Feb 03, 2025 |
|
Advancing Prevention: Insights From JACC's Focus Issue
|
Feb 03, 2025 |
|
JACC - Transforming Publishing: Your Paper, Your Way at JACC
|
Jan 28, 2025 |
|
Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure Medications: A State-of-the-Art Review
|
Jan 27, 2025 |
|
2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis
|
Jan 27, 2025 |
|
The Association of Hospital-Cardiologist Integration with Patient Outcomes, Care Quality, and Utilization
|
Jan 27, 2025 |
|
Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease
|
Jan 27, 2025 |
|
P2Y12 Inhibitor Pretreatment in Non-ST Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry
|
Jan 27, 2025 |
|
A Contemporary Picture of Coagulase-negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study
|
Jan 27, 2025 |
|
JACC - February 4, 2025 Issue Summary
|
Jan 27, 2025 |
|
Advances in Transcatheter Tricuspid Valve Interventions: Implications for Health Policy
|
Jan 20, 2025 |
|
Transcatheter Interventions in Tricuspid Regurgitation: Shifting the Focus Beyond Quantity of Life to Quality of Life
|
Jan 20, 2025 |
|
Amara Yad Image: The Tricuspid Valve
|
Jan 20, 2025 |
|
The Amara Yad Project: A New Resource for Cardiac Anatomy
|
Jan 20, 2025 |
|
Transcatheter Tricuspid Valve Replacement
|
Jan 20, 2025 |
|
Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling: The TRILUMINATE Pivotal Imaging Substudy
|
Jan 20, 2025 |
|
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort
|
Jan 20, 2025 |
|
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry
|
Jan 20, 2025 |
|
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial
|
Jan 20, 2025 |
|
Tricuspid Valve Interventions: A New Era in Cardiovascular Innovation
|
Jan 20, 2025 |
|
Did Finerenone Improve Health Status in the FINEARTS Trial?: A Critical Reevaluation of the Analysis of Patient-Reported Outcomes in Heart Failure
|
Jan 13, 2025 |
|
Initial Decline In Glomerular Filtration Rate With Finerenone In Hfmref/Hfpef: a Prespecified Analysis of Finearts-Hf
|
Jan 13, 2025 |
|
Finerenone And Kidney Outcomes In Patients With Heart Failure: the Finearts-Hf Trial
|
Jan 13, 2025 |
|
Finerenone, Obesity, And Heart Failure With Mildly Reduced/Preserved Ejection Fraction: a Prespecified Analysis of Finearts-Hf
|
Jan 13, 2025 |
|
Effect of Finerenone On the Kccq In Patients With Hfmref/Hfpef: a Prespecified Analysis of Finearts-Hf
|
Jan 13, 2025 |
|
Use of Finerenone For Heart Failure And Intermediate Or Preserved Ejection Fraction: the Finearts-Hf Trial
|
Jan 13, 2025 |
|
A Comprehensive Exploration of FINEARTS-HF: A JACC Theme Issue
|
Jan 13, 2025 |
|
JACC - Obesity as a Disease | JACC
|
Jan 09, 2025 |
|
JACC - The Terminology of Obesity | JACC
|
Jan 09, 2025 |
|
JACC - Obesity Medication Usage | JACC
|
Jan 09, 2025 |
|
JACC - Obesity Medication Concerns | JACC
|
Jan 09, 2025 |
|
JACC - Shame and Blame | JACC
|
Jan 09, 2025 |
|
JACC - Is There Healthy Obesity? | JACC
|
Jan 09, 2025 |
|
JACC - The Cardiologist's Role in Treating Obesity | JACC
|
Jan 09, 2025 |
|
JACC - Should Cardiologists Care About Obesity? | JACC
|
Jan 09, 2025 |
|
Effect of valve type and anesthesia strategy for TAVR – 5-year results of the SOLVE-TAVI trial
|
Jan 06, 2025 |
|
Association of Systemic Thromboxane Generation with Risk of Developing Heart Failure
|
Jan 06, 2025 |
|
Machine Learning-based Prediction of Death and Hospitalization in Patients with Implantable Cardioverter Defibrillators
|
Jan 06, 2025 |
|
Optimal Strategy for Complete Revascularization in ST-Elevation Myocardial Infarction and Multivessel Disease: A Network Meta-Analysis
|
Jan 06, 2025 |
|
Drug-Coated Balloon Angioplasty Of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial
|
Jan 06, 2025 |
|
JACC - January 7 - 14, 2025 Issue Summary
|
Jan 06, 2025 |
|
Anatomic and Physiologic Repair of Congenitally Corrected Transposition of the Great Arteries
|
Dec 09, 2024 |
|
Excess Mortality and Hospitalizations Associated with Seasonal Influenza in Patients with Heart Failure
|
Dec 09, 2024 |
|
Impact of Renal & Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair
|
Dec 09, 2024 |
|
Oxidized Phospholipids and Calcific Aortic Valvular Disease
|
Dec 09, 2024 |
|
Cardiac MRI Predictors of Arrhythmic Sudden Cardiac Events in Patients with Fontan Circulation
|
Dec 09, 2024 |
|
JACC - December 17 - 24, 2024 Issue Summary
|
Dec 09, 2024 |
|
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared with Placebo for Initial Treatment of Hypertension
|
Dec 02, 2024 |
|
Aspirin Monotherapy versus No Antiplatelet Therapy in Stable Patients with Coronary Stents Undergoing Low-to-Intermediate Risk Non-cardiac Surgery
|
Dec 02, 2024 |
|
Percutaneous Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation in Heart Failure: A Meta-analysis of Randomized Controlled Trials
|
Dec 02, 2024 |
|
Hospitalizations in Symptomatic Patients with Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights from RESHAPE-HF2
|
Dec 02, 2024 |
|
Major Bleeding and Mortality After Revascularization of Left Main Disease
|
Dec 02, 2024 |
|
JACC - December 10, 2024 Issue Summary
|
Dec 02, 2024 |
|
Sudden Death in Obesity: Mechanisms and Management
|
Nov 25, 2024 |
|
Length of Hospital Stay for Endocarditis. Before and After Partial Oral Treatment of Endocarditis Trial
|
Nov 25, 2024 |
|
Artificial Intelligence-Enhanced Electrocardiogram Diastolic Function Assessment for Prognostic Stratification in Mitral Regurgitation
|
Nov 25, 2024 |
|
Hypertensive disorders of pregnancy increase risk for myocardial infarction: a population-based study
|
Nov 25, 2024 |
|
Two-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study
|
Nov 25, 2024 |
|
JACC - December 3, 2024 Issue Summary
|
Nov 25, 2024 |
|
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of Four Trials
|
Nov 21, 2024 |
|
JACC - SUMMIT 2024: A Video Interview with Harlan Krumholz and Milton Packer| JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Recap of AHA From Harlan Krumholz, Editor-in-Chief
|
Nov 20, 2024 |
|
JACC - Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure
|
Nov 20, 2024 |
|
JACC - Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
|
Nov 20, 2024 |
|
JACC - Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy
|
Nov 20, 2024 |
|
JACC - Outpatient Worsening Heart Failure in Patients with ATTR CM in the HELIOS-B Trial | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Five-Year Results from the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
|
Nov 20, 2024 |
|
JACC - Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
|
Nov 20, 2024 |
|
JACC - DanGer Shock trial: The impact of age | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Oxidized Phospholipids and Calcific Aortic Valvular Disease
|
Nov 20, 2024 |
|
JACC - Accelerometer-Measured Sedentary Behavior & Risk of Future Cardiovascular Disease | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - P2Y12 Inhibitor Pretreatment in Non-ST Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry
|
Nov 20, 2024 |
|
JACC - Hospital-Cardiologist Integration and Outcomes | JACC | AHA 2024
|
Nov 20, 2024 |
|
JACC - Rural-Urban Differences in Cardiovascular Mortality in the United States, 2010-2022
|
Nov 20, 2024 |
|
Consequences of Discontinuation of Long-Term Treatment in Patients With Heart Failure and Reduced Ejection Fraction
|
Nov 18, 2024 |
|
Clinical implications of Pre-test probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension
|
Nov 18, 2024 |
|
ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
|
Nov 18, 2024 |
|
Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis
|
Nov 18, 2024 |
|
Associations of Self-reported Race, Polygenic Risk, and Social Determinants of Health with Coronary Heart Disease
|
Nov 18, 2024 |
|
JACC - November 26, 2024 Issue Summary
|
Nov 18, 2024 |
|
JACC Journals at AHA | JACC | AHA 2024
|
Nov 13, 2024 |
|
Ten Years of Leadless Cardiac Pacing
|
Nov 11, 2024 |
|
Embryological Classification of Arrhythmogenic Triggers Initiating Atrial Fibrillation
|
Nov 11, 2024 |
|
Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease
|
Nov 11, 2024 |
|
Non-Modifiable Risk Factors Predict Outcomes in Brugada Syndrome
|
Nov 11, 2024 |
|
Screening for Undiagnosed Atrial Fibrillation and Stroke Prevention
|
Nov 11, 2024 |
|
JACC - November 19, 2024 Issue Summary
|
Nov 11, 2024 |
|
Artificial Intelligence in Cardiovascular Clinical Trials
|
Nov 04, 2024 |
|
Recaticimab as add-on therapy to statins for non-familial hypercholesterolaemia: the phase 3 REMAIN-2 trial
|
Nov 04, 2024 |
|
Recaticimab Monotherapy for Non-Familial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
|
Nov 04, 2024 |
|
Complete vs. Culprit-Only Revascularization in Older Patients with Myocardial Infarction with or without ST-segment elevation
|
Nov 04, 2024 |
|
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy
|
Nov 04, 2024 |
|
Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Heart Failure: a EMPEROR Validation Cohort
|
Nov 04, 2024 |
|
JACC - November 12, 2024 Issue Summary
|
Nov 04, 2024 |
|
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs. Second-Generation DES: TARGET-IV NA Trial
|
Oct 30, 2024 |
|
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial
|
Oct 30, 2024 |
|
Drug-Coated Balloon Angioplasty Of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial
|
Oct 28, 2024 |
|
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD
|
Oct 28, 2024 |
|
Family Screening in Hypertrophic Cardiomyopathy - Identification of Relatives with Low Yield from Systematic Follow-up
|
Oct 28, 2024 |
|
Standard of Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
|
Oct 28, 2024 |
|
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
|
Oct 28, 2024 |
|
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
|
Oct 28, 2024 |
|
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
|
Oct 28, 2024 |
|
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
|
Oct 28, 2024 |
|
JACC - November 5, 2024 Issue Summary
|
Oct 28, 2024 |
|
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry
|
Oct 27, 2024 |
|
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-year Outcomes From the TRILUMINATE Randomized Cohort
|
Oct 27, 2024 |
|
Aspirin Hypersensitivity in Patients with Atherosclerotic Cardiovascular Disease
|
Oct 21, 2024 |
|
AI-Facilitated Assessment of Built Environment Using Neighborhood Satellite Imagery and Cardiovascular Risk
|
Oct 21, 2024 |
|
FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction
|
Oct 21, 2024 |
|
The IRONMAN trial of intravenous iron for heart failure. Adjudication of hospitalizations and deaths.
|
Oct 21, 2024 |
|
Asymptomatic versus symptomatic hypotension with sacubitril/valsartan in heart failure and reduced ejection fraction in PARADIGM-HF
|
Oct 21, 2024 |
|
JACC - October 29, 2024 Issue Summary
|
Oct 21, 2024 |
|
Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program
|
Oct 14, 2024 |
|
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths - An Analysis From the SELECT Trial
|
Oct 14, 2024 |
|
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease (FLOW Trial)
|
Oct 14, 2024 |
|
Atrial fibrillation and semaglutide efficacy in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF Program
|
Oct 14, 2024 |
|
Effect of Semaglutide on Cardiac Structure and Function in Patients with Obesity-Related Heart Failure
|
Oct 14, 2024 |
|
JACC - October 22, 2024 Issue Summary
|
Oct 14, 2024 |
|
JACC - The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial | EACTS 2024
|
Oct 11, 2024 |
|
International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence.
|
Oct 07, 2024 |
|
Urinary Metal Levels and Coronary Artery Calcification: Longitudinal Evidence in the Multi-Ethnic Study of Atherosclerosis
|
Oct 07, 2024 |
|
Heart failure risk assessment using biomarkers in patients with atrial fibrillation: Analysis from COMBINE-AF
|
Oct 07, 2024 |
|
Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results
|
Oct 07, 2024 |
|
Minimum National Prevalence of Diagnosed Atrial Fibrillation inferred from California Acute Care Facilities
|
Oct 07, 2024 |
|
JACC - October 15, 2024 Issue Summary
|
Oct 07, 2024 |
|
Part Two: Time to Significant Benefit of Finerenone in Patients With Heart Failure | JACC | HFSA 2024
|
Oct 04, 2024 |
|
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial | JACC | HFSA 2024
|
Oct 04, 2024 |
|
ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery
|
Sep 30, 2024 |
|
Contemporary Training in American Critical Care Cardiology: Minnesota Critical Care Cardiology Education Summit
|
Sep 30, 2024 |
|
Risk of Ischemic Stroke After Patent Foramen Ovale Closure
|
Sep 30, 2024 |
|
Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients with Non-ischemic Cardiomyopathy
|
Sep 30, 2024 |
|
Influence of subclinical atherosclerosis burden and progression on mortality
|
Sep 30, 2024 |
|
Prognostic Implications of Clinical- and Imaging Diagnostic Criteria for Myocarditis
|
Sep 30, 2024 |
|
JACC - October 8, 2024 Issue Summary
|
Sep 30, 2024 |
|
Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
|
Sep 28, 2024 |
|
2024 ACC/AHA Key Data Elements and Definitions for Social Determinants of Health in Cardiology
|
Sep 23, 2024 |
|
Implantable Cardioverter Defibrillator and Resynchronization Therapy in Patients with Overt Chronic Kidney Disease: JACC State-of-the-Art Review
|
Sep 23, 2024 |
|
Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol
|
Sep 23, 2024 |
|
Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults
|
Sep 23, 2024 |
|
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients with Heart Failure and Hyperkalemia
|
Sep 23, 2024 |
|
Outcomes of Patients Undergoing Surgery for Complete Vascular Rings
|
Sep 23, 2024 |
|
JACC - October 1, 2024 Issue Summary
|
Sep 23, 2024 |
|
Urinary Metal Levels and Coronary Artery Calcification: Longitudinal Evidence in the Multi-Ethnic Study of Atherosclerosis
|
Sep 20, 2024 |
|
Interactions of Sleep Apnea with the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review
|
Sep 16, 2024 |
|
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update: A Report of the American College of Cardiology Solution Set Oversight Committee
|
Sep 16, 2024 |
|
Predicting Long-term Clinical Outcomes of Patients with Recurrent Pericarditis
|
Sep 16, 2024 |
|
Temporal Trends in Takotsubo Syndrome - Results from the International Takotsubo Registry
|
Sep 16, 2024 |
|
Recovery of Left Ventricular Function and Long-term Outcomes in Patients with Takotsubo Syndrome
|
Sep 16, 2024 |
|
Short-term effects of lower air temperature and cold spells on myocardial infarction hospitalizations in Sweden
|
Sep 16, 2024 |
|
JACC - September 24, 2024 Issue Summary
|
Sep 16, 2024 |
|
Genotype Guided Antiplatelet Therapy: JACC Review Topic of the Week
|
Sep 09, 2024 |
|
Prognostic value of plasma IgG N-glycome traits in pulmonary arterial hypertension
|
Sep 09, 2024 |
|
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
|
Sep 09, 2024 |
|
Effect of Evogliptin on the Progression of Aortic Valvular Calcification
|
Sep 09, 2024 |
|
Adverse Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea and Obesity: Metabolic Surgery versus Usual Care
|
Sep 09, 2024 |
|
JACC - September 17, 2024 Issue Summary
|
Sep 09, 2024 |
|
RESHAPE-HF2 Trial Findings | ESC 2024
|
Sep 06, 2024 |
|
Effect of Screening for Undiagnosed Atrial Fibrillation and on Stroke Prevention | ESC Congress
|
Sep 05, 2024 |
|
Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
|
Sep 03, 2024 |
|
Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
|
Sep 03, 2024 |
|
Association of Postnatal Opioid Exposure and 2-year Neurodevelopmental Outcomes in Infants Undergoing Cardiac Surgery
|
Sep 02, 2024 |
|
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
|
Sep 02, 2024 |
|
Serial Shock Severity Assessment Within Seventy-Two Hours after Diagnosis: A Cardiogenic Shock Working Group Report
|
Sep 02, 2024 |
|
Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood
|
Sep 02, 2024 |
|
JACC - September 10, 2024 Issue Summary
|
Sep 02, 2024 |
|
Serial Shock Severity Assessment: Some Answers. Still Many Questions. | ESC 2024
|
Aug 31, 2024 |
|
Insights from RESHAPE-HF2 Trial | ESC 2024
|
Aug 31, 2024 |
|
A Secondary Analysis of DANFLU-1 Trial - High vs Standard Dose Influenza Vaccine in CKD | ESC 2024
|
Aug 31, 2024 |
|
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
|
Aug 30, 2024 |
|
Updates from the STEP-HFpEF Trial | ESC 2024
|
Aug 30, 2024 |
|
An Analysis From the SELECT Trial - COVID-19| ESC 2024
|
Aug 30, 2024 |
|
Insights from the FLOW Trial | ESC 2024
|
Aug 30, 2024 |
|
Antithrombotic Strategies for Patients with Peripheral Artery Disease: JACC Scientific Statement
|
Aug 26, 2024 |
|
Continuous Rhythm Monitoring with Implanted Loop Recorders in Children and Adolescents with Brugada Syndrome
|
Aug 26, 2024 |
|
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM
|
Aug 26, 2024 |
|
Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Watchman FLX Left Atrial Appendage Occlusion
|
Aug 26, 2024 |
|
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-way Comparison from AUGUSTUS
|
Aug 26, 2024 |
|
JACC - September 3, 2024 Issue Summary
|
Aug 26, 2024 |
|
Treatment of Transcatheter Aortic Valve Thrombosis: JACC Review Topic of the Week
|
Aug 19, 2024 |
|
Structural Cardiac Interventions in Patients with Heart Failure: JACC Scientific Statement
|
Aug 19, 2024 |
|
Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease
|
Aug 19, 2024 |
|
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization
|
Aug 19, 2024 |
|
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results
|
Aug 19, 2024 |
|
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials
|
Aug 19, 2024 |
|
JACC - August 27, 2024 Issue Summary
|
Aug 19, 2024 |
|
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions
|
Aug 12, 2024 |
|
Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay
|
Aug 12, 2024 |
|
Clinical Significance of Diffusion-Weighted Brain MRI Lesions After TAVR: Results of a Patient-Level Pooled Analysis
|
Aug 12, 2024 |
|
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors Versus GLP-1 Receptor Agonists in Type 2 Diabetes
|
Aug 12, 2024 |
|
Prescription Patterns for Sodium Glucose Cotransporter-2 Inhibitors in US Health Systems
|
Aug 12, 2024 |
|
JACC - August 20, 2024 Issue Summary
|
Aug 12, 2024 |
|
Ending trans fat-the first-ever global elimination program for a noncommunicable disease risk factor: JACC International
|
Aug 05, 2024 |
|
Myocardial Strain Measured by Magnetic Resonance Imaging Predicts Cardiovascular Morbidity and Death
|
Aug 05, 2024 |
|
Comparison of Pressure vs Volume Overload Ventricular Wall Stress in Patients with Valvular Heart Disease
|
Aug 05, 2024 |
|
Contemporary Pediatric Heart Transplant Waitlist Mortality
|
Aug 05, 2024 |
|
Real-world 1-Year Results of Tricuspid Edge-to-Edge Repair from the bRIGHT Study
|
Aug 05, 2024 |
|
JACC - August 13, 2024 Issue Summary
|
Aug 05, 2024 |
|
Pericardial Diseases and Best Practices for Pericardiectomy: JACC State-of-the-Art Review
|
Jul 29, 2024 |
|
Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients with Type 2 Diabetes
|
Jul 29, 2024 |
|
A Patch Wearable Cardioverter Defibrillator for Patients at Risk of Sudden Cardiac Arrest
|
Jul 29, 2024 |
|
The influence of epicardial resistance on microvascular resistance reserve
|
Jul 29, 2024 |
|
Effect of Time-Varying Exposure to School-Based Health Promotion on Adiposity in Childhood
|
Jul 29, 2024 |
|
JACC - August 6, 2024 Issue Summary
|
Jul 29, 2024 |
|
Treating Depression to Improve Survival in Coronary Heart Disease: What Have We Learned?
|
Jul 22, 2024 |
|
Mortality after Procedural or Spontaneous Myocardial Infarction
|
Jul 22, 2024 |
|
Temperature and Neurologic Outcomes in Neonates Undergoing Cardiac Surgery: A Society of Thoracic Surgeons Study
|
Jul 22, 2024 |
|
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention
|
Jul 22, 2024 |
|
Association of Adverse Clinical Outcomes with Peri-Infarct Ischemia Detected by Stress Cardiac Magnetic Imaging
|
Jul 22, 2024 |
|
JACC - July 30, 2024 Issue Summary
|
Jul 22, 2024 |
|
Sutureless Valves, a "Wireless" Option for Patients with Aortic Valve Disease: JACC State-of-the-Art Review
|
Jul 15, 2024 |
|
OCT-Guided vs Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy
|
Jul 15, 2024 |
|
Apixaban versus Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights from ARTESiA
|
Jul 15, 2024 |
|
Impact of Anatomical and Viability-guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy
|
Jul 15, 2024 |
|
Effects of Rapid Up-Titration of Neurohormonal Blockade in Patients with Acute Decompensated Heart Failure
|
Jul 15, 2024 |
|
JACC - July 23, 2024 Issue Summary
|
Jul 15, 2024 |
|
The Role of Psychosocial Stress on Cardiovascular disease in Women: JACC-State-of-the-Art-Review
|
Jul 08, 2024 |
|
Percutaneous coronary revascularization strategies after myocardial infarction: a systematic review and network meta-analysis
|
Jul 08, 2024 |
|
Glycemic Control and Coronary Stent Failure in Patients with Type 2 Diabetes Mellitus
|
Jul 08, 2024 |
|
Semaglutide and NYHA Class in Obesity-Related Heart Failure with Preserved Ejection Fraction: the STEP-HFpEF Program
|
Jul 08, 2024 |
|
Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial
|
Jul 08, 2024 |
|
JACC - July 16, 2024 Issue Summary
|
Jul 08, 2024 |
|
Tricuspid Regurgitation in Patients with Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review
|
Jul 01, 2024 |
|
Coronary artery bypass graft failure in women: incidence and clinical implications
|
Jul 01, 2024 |
|
Impact of Lp(a) Level on LDL-Cholesterol or Apolipoprotein B-Related Risk of Coronary Heart Disease
|
Jul 01, 2024 |
|
Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs
|
Jul 01, 2024 |
|
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients with Diabetic Cardiomyopathy
|
Jul 01, 2024 |
|
JACC - July 9, 2024 Issue Summary
|
Jul 01, 2024 |
|
Transforming Cardiovascular Care with Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review
|
Jun 24, 2024 |
|
Lessons for Cardiovascular Clinical Investigators: the Tumultuous 2500-Year Journey of Physicians Who Ignited Our Fire
|
Jun 24, 2024 |
|
Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden
|
Jun 24, 2024 |
|
Prognostic Value of a 6-Minute Walk Test in Patients with Cardiac Transthyretin Amyloidosis
|
Jun 24, 2024 |
|
Semaglutide and NTproBNP in Obesity-Related HFpEF: Insights from STEP-HFpEF Program
|
Jun 24, 2024 |
|
N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention
|
Jun 24, 2024 |
|
Symptoms as a predictor of the placebo-controlled efficacy of PCI in stable coronary artery disease
|
Jun 24, 2024 |
|
JACC - July 2, 2024 Issue Summary
|
Jun 24, 2024 |
|
Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review
|
Jun 17, 2024 |
|
Intravenous Iron Repletion for Patients with Heart Failure and Iron Deficiency: JACC State-of-the-Art Review
|
Jun 17, 2024 |
|
Randomized Trial of a Vascular Care Team vs Education for Patients with Peripheral Artery Disease
|
Jun 17, 2024 |
|
Association of Autoimmune Diseases with Coronary Atherosclerosis Severity and Ischemic Events
|
Jun 17, 2024 |
|
Timing of P2Y12-inhibitor Administration in Patients with STEMI Undergoing Primary PCI
|
Jun 17, 2024 |
|
Ten-Year Mortality after ST-Segment Elevation Myocardial Infarction Compared to the General Population
|
Jun 17, 2024 |
|
JACC - June 25, 2024 Issue Summary
|
Jun 17, 2024 |
|
Artificial Intelligence in Cardiovascular Care — Part 2: Applications: JACC Review Topic of the Week
|
Jun 10, 2024 |
|
Artificial Intelligence for Cardiovascular Care — Part 1: Advances : JACC Review Topic of the Week
|
Jun 10, 2024 |
|
2024 ACC/AHA/AACVPR/APMA/ ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
|
Jun 10, 2024 |
|
Geographical Mapping of Gender Disparities in Authorship of Cardiovascular Literature
|
Jun 10, 2024 |
|
Impact of Social Determinants of Health on Predictive Models for Outcomes after Congenital Heart Surgery
|
Jun 10, 2024 |
|
Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Impaired Renal Function
|
Jun 10, 2024 |
|
SGLT2 Inhibitor Therapy in Patients with Transthyretin Amyloid Cardiomyopathy
|
Jun 10, 2024 |
|
JACC - June 18, 2024 Issue Summary
|
Jun 10, 2024 |
|
Pollution and Cardiovascular Disease, Part 1: Environmentally Not So Friendly:Global Warming, Air Pollution,and Wildfires: JACC Focus Seminar
|
Jun 03, 2024 |
|
Pollution and Cardiovascular Disease, Part 2: Water, Soil, Noise and Light Pollution: JACC Focus Seminar
|
Jun 03, 2024 |
|
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
|
Jun 03, 2024 |
|
Global, and Regional Cardiovascular Mortality Attributable to Non-optimal Temperatures over Time
|
Jun 03, 2024 |
|
Excess Apolipoprotein B and Cardiovascular Risk in Women and Men
|
Jun 03, 2024 |
|
Randomized Trial of Remote Assessment of Patients after an Acute Coronary Syndrome
|
Jun 03, 2024 |
|
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
|
Jun 03, 2024 |
|
JACC - June 11, 2024 Issue Summary
|
Jun 03, 2024 |
|
Reperfusion Injury in Patients with Acute Myocardial Infarction: JACC: Scientific Statement
|
May 26, 2024 |
|
Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review
|
May 26, 2024 |
|
Transcatheter Covered Stent Exclusion of Superior Sinus Venosus Defects
|
May 26, 2024 |
|
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
|
May 26, 2024 |
|
Effects of Sacubitril/Valsartan in Patients with Heart Failure Across the Spectrum of Kidney Risk
|
May 26, 2024 |
|
Coronary Atherosclerotic Plaque Activity and Myocardial Infarction: A vessel-level analysis of the PRE18FFIR study
|
May 26, 2024 |
|
JACC - June 4, 2024 Issue Summary
|
May 26, 2024 |
|
Clinical Risk Assessment Across the Lifespan in Patients with Congenital Heart Disease: JACC Scientific Statement
|
May 20, 2024 |
|
Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review
|
May 20, 2024 |
|
A Technology-Assisted Web Application for Consumer Access to a Non-prescription Statin Medication
|
May 20, 2024 |
|
Prognostic Value of MRR After Primary PCI: a Pooled Analysis of Individual Patient Data
|
May 20, 2024 |
|
Clinical Outcome of Different Microvascular Injury Patterns after STEMI - A Multicenter Cardiac MRI Study
|
May 20, 2024 |
|
Safety and Efficacy of Metabolic Modulation with Ninerafaxstat in Nonobstructive Hypertrophic Cardiomyopathy: Phase 2 Study
|
May 20, 2024 |
|
JACC - May 28, 2024 Issue Summary
|
May 20, 2024 |
|
Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week
|
May 13, 2024 |
|
Managing Implanted Cardiac Electronic Devices in Patients with Severe Tricuspid Regurgitation: JACC State-of-the-Art Review
|
May 13, 2024 |
|
Case Volumes and Outcomes among Early Career Interventional Cardiologists in the United States
|
May 13, 2024 |
|
Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial
|
May 13, 2024 |
|
Small Left Ventricle is Associated with an Increased Cardiovascular Risk in Patients with Atrial Fibrillation
|
May 13, 2024 |
|
An Inclisiran First Strategy vs Usual Care in Patients with Atherosclerotic Cardiovascular Disease
|
May 13, 2024 |
|
JACC - May 21, 2024 Issue Summary
|
May 13, 2024 |
|
Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5
|
May 06, 2024 |
|
Long-term Cardiovascular Risk Associated with Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
|
May 06, 2024 |
|
Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule Out Myocardial Infarction at Presentation
|
May 06, 2024 |
|
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Cardiomyopathies
|
May 06, 2024 |
|
Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members
|
May 06, 2024 |
|
JACC - May 14, 2024 Issue Summary
|
May 06, 2024 |
|
JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction
|
Apr 29, 2024 |
|
Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients with Obstructive Sleep Apnea
|
Apr 29, 2024 |
|
Association of Lipoprotein(a) Levels with Myocardial Infarction in Patients with Low Attenuation Plaque
|
Apr 29, 2024 |
|
Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction
|
Apr 29, 2024 |
|
Combined effects of clonal hematopoiesis and degree of carotid stenosis on cardiovascular mortality
|
Apr 29, 2024 |
|
JACC - May 7, 2024 Issue Summary
|
Apr 29, 2024 |
|
Malignant Hypertension – A Systemic Cardiovascular Disease: JACC Review Topic of the Week
|
Apr 22, 2024 |
|
Association of Disrupted Delta Wave Activity During Sleep with Long-Term Cardiovascular Disease and Mortality
|
Apr 22, 2024 |
|
Permanent Pacemaker Implantation and Long-term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery
|
Apr 22, 2024 |
|
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
|
Apr 22, 2024 |
|
Limb Outcomes with Ticagrelor Plus Aspirin in Patients with Diabetes Mellitus and Atherosclerosis
|
Apr 22, 2024 |
|
JACC - April 30, 2024 Issue Summary
|
Apr 22, 2024 |
|
The Clinical Challenge of Prosthetic Valve Endocarditis: JACC Focus Seminar
|
Apr 08, 2024 |
|
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
|
Apr 08, 2024 |
|
Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults with Congenital Heart Disease
|
Apr 08, 2024 |
|
Water Conservation Overrides Osmotic Diuresis during SGLT2 Inhibition in Patients with Heart Failure
|
Apr 08, 2024 |
|
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score
|
Apr 08, 2024 |
|
Variation in Health Status with Invasive vs Conservative Management of Chronic Coronary Disease
|
Apr 08, 2024 |
|
JACC - April 16, 2024 Issue Summary
|
Apr 08, 2024 |
|
Today's Infective Endocarditis: Not What You Learned in Medical School
|
Apr 01, 2024 |
|
Early Outcomes from a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry
|
Apr 01, 2024 |
|
Efficacy and Safety of Dapagliflozin in Patients with Acute Heart Failure
|
Apr 01, 2024 |
|
Stratifying Disease Progression in Patients with Cardiac ATTR Amyloidosis
|
Apr 01, 2024 |
|
Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction
|
Apr 01, 2024 |
|
JACC - April 9, 2024 Issue Summary
|
Apr 01, 2024 |
|
Fetal Hemodynamics, Early Survival, and Neurodevelopment in Patients with Cyanotic Congenital Heart Disease
|
Mar 25, 2024 |
|
Mortality in a Nationwide Practice-Based Cohort Receiving Paclitaxel-Coated Devices for Lower Limb Peripheral Artery Disease
|
Mar 25, 2024 |
|
Risk of Dementia During Antihypertensive Drug Therapy in the Elderly
|
Mar 25, 2024 |
|
Validation of the ACC Expert Consensus Decision Pathway for Patients with Chest Pain
|
Mar 25, 2024 |
|
JACC - April 2, 2024 Issue Summary
|
Mar 25, 2024 |
|
Genetic Factors Altering Immune Responses in Atrial Fibrillation: JACC Review Topic of the Week
|
Mar 18, 2024 |
|
Frailty and Cognitive Function in Middle-Aged and Older Adults With Congenital Heart Disease
|
Mar 18, 2024 |
|
Coarctation of Aorta With Tricuspid Aortic Valve Is Not Associated With Ascending Aortic Aneurysm
|
Mar 18, 2024 |
|
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
|
Mar 18, 2024 |
|
Prevalence and Outcomes of Patients With Discordant High-Gradient Aortic Stenosis
|
Mar 18, 2024 |
|
JACC - March 26, 2024 Issue Summary
|
Mar 18, 2024 |
|
Histological Typing in Patients with Cardiac Amyloidosis: JACC Review Topic of the Week
|
Mar 11, 2024 |
|
Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease
|
Mar 11, 2024 |
|
Kidney Injury After Minimal Radiographic Contrast Administration in Patients with Acute Coronary Syndromes
|
Mar 11, 2024 |
|
Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography
|
Mar 11, 2024 |
|
Association of Antiarrhythmic Drug Therapy with Syncope and Pacemaker Implantation in Patients with Atrial Fibrillation
|
Mar 11, 2024 |
|
JACC - March 19, 2024 Issue Summary
|
Mar 11, 2024 |
|
JACC - March 12, 2024 Issue Summary: Dr. Valentin Fuster's Top Picks for 2023
|
Mar 04, 2024 |
|
Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review
|
Feb 26, 2024 |
|
Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting
|
Feb 26, 2024 |
|
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
|
Feb 26, 2024 |
|
Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease
|
Feb 26, 2024 |
|
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease
|
Feb 26, 2024 |
|
JACC - March 5, 2024 Issue Summary
|
Feb 26, 2024 |
|
"Food Is Medicine" Strategies for Nutrition Security and Cardiometabolic Health Equity: JACC State-of-the-Art Review
|
Feb 19, 2024 |
|
Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer
|
Feb 19, 2024 |
|
Infective Endocarditis in Patients Addicted to Injected Opioid Drugs
|
Feb 19, 2024 |
|
Phenotypic Expression and Clinical Outcomes in Patients with Arrhythmogenic Cardiomyopathies
|
Feb 19, 2024 |
|
" Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality"
|
Feb 19, 2024 |
|
JACC - February 27, 2024 Issue Summary
|
Feb 19, 2024 |
|
Participation In Competitive Sports By Patients With Congenital Heart Disease: Aha/Acc And Eapc/Esc/Aepc Guidelines Comparison
|
Feb 12, 2024 |
|
Vascular Regenerative Cell Deficiencies In South Asian Adults
|
Feb 12, 2024 |
|
Increased Risk of Myocardial Infarction, Heart Failure And Atrial Fibrillation After Spinal Cord Injury
|
Feb 12, 2024 |
|
Intrahepatic Transcriptomics Differentiate Advanced Fibrosis And Clinical Outcomes In Adults With Fontan Circulation
|
Feb 12, 2024 |
|
Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults
|
Feb 12, 2024 |
|
JACC - February 20, 2024 Issue Summary
|
Feb 12, 2024 |
|
Measuring Coronary Blood Flow And Microvascular Resistance By Thermodilution: JACC Review Topic of the Week
|
Feb 05, 2024 |
|
Implantable Hemodynamic Monitors Improve Survival In Patients With Heart Failure And Reduced Ejection Fraction
|
Feb 05, 2024 |
|
Bleeding Outcomes In Patients Treated With Asundexian In Phase Ii Trials
|
Feb 05, 2024 |
|
Long-Term Efficacy of Evolocumab In Patients With Or Without Multivessel Coronary Disease
|
Feb 05, 2024 |
|
Randomized Trial of Effect of Bariatric Surgery On Blood Pressure After Five Years
|
Feb 05, 2024 |
|
JACC - February 13, 2024 Issue Summary
|
Feb 05, 2024 |
|
Clinical Presentation, Classification, And Outcomes of Cardiogenic Shock In Children
|
Jan 29, 2024 |
|
Large-Scale Proteomics Identifies Novel Biomarkers And Circulating Risk Factors For Aortic Stenosis
|
Jan 29, 2024 |
|
Universal Risk Prediction For Individuals With And Without Atherosclerotic Cardiovascular Disease
|
Jan 29, 2024 |
|
Outcomes According To Coronary Revascularization Modality In the Ischemia Trial
|
Jan 29, 2024 |
|
JACC - February 6, 2024 Issue Summary
|
Jan 29, 2024 |
|
Racial And Ethnic Disparities In Perioperative Health Care Among Patients Undergoing Cardiac Surgery: JACC State-of-the-Art Review
|
Jan 22, 2024 |
|
Growth of the Neo-Aortic Root And Prognosis of Transposition of the Great Arteries
|
Jan 22, 2024 |
|
Prognostic Implications of Initial Focal Contrast Enhancement In Acute Type B Intramural Hematoma
|
Jan 22, 2024 |
|
Transcatheter Edge-To-Edge Repair In Coapt-Ineligible Patients With Functional Mitral Regurgitation
|
Jan 22, 2024 |
|
Randomized Trial of Macitentan/Tadalafil Combination Therapy For Pulmonary Artery Hypertension
|
Jan 22, 2024 |
|
JACC - January 30, 2024 Issue Summary
|
Jan 22, 2024 |
|
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review
|
Jan 15, 2024 |
|
Anxiety And Depression Symptoms In An International Study of Adults With Congenital Heart Disease
|
Jan 15, 2024 |
|
Risk of Death In Patients With Coronary Artery Disease Taking Nitrates And Phosphodiesterase-5-Inhibitors
|
Jan 15, 2024 |
|
Guiding Intervention For Complex Coronary Lesions By Optical Coherence Tomography Or Intravascular Ultrasound
|
Jan 15, 2024 |
|
Lipoprotein(A) is Markedly More Atherogenic Than Ldl: An Apolipoprotein B-Based Genetic Analysis
|
Jan 15, 2024 |
|
JACC - January 23, 2024 Issue Summary
|
Jan 15, 2024 |
|
Sudden Cardiac Death In Young Athletes: Jacc State-Of-The-Art Review
|
Jan 08, 2024 |
|
Comparison of Direct Oral Anticoagulants Vs Vitamin-K Antagonists After Transcatheter Mitral Valve Replacement
|
Jan 08, 2024 |
|
Cardiac Reoperation Or Transcatheter Mitral Valve Replacement For Patients With Failed Mitral Prostheses
|
Jan 08, 2024 |
|
Sex-Specific Prognosis of Left Ventricular Size And Function Following Repair of Degenerative Mitral Regurgitation
|
Jan 08, 2024 |
|
Rethinking False Positive Exercise Electrocardiographic Stress Tests By Assessing Coronary Microvascular Function
|
Jan 08, 2024 |
|
JACC - January 16, 2024 Issue Summary
|
Jan 08, 2024 |
|
2023 Acc/Aha/Accp/Hrs Guideline For the Diagnosis And Management of Atrial Fibrillation
|
Jan 02, 2024 |
|
Antithrombotic Therapy For Patients Undergoing Cardiac Electrophysiological And Interventional Procedures: Jacc State-Of-The-Art Review
|
Jan 02, 2024 |
|
Lung-To-Heart Nano-In-Micro Peptide Promotes Cardiac Recovery In a Pig Model of Chronic Heart Failure
|
Jan 02, 2024 |
|
Contemporary Management And Outcomes of Patients With High-Risk Pulmonary Embolism
|
Jan 02, 2024 |
|
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After Pci: Stopdapt-2 5-Year Results
|
Jan 02, 2024 |
|
Health Status After Transcatheter Tricuspid-Valve Repair In Patients With Severe Tricuspid Regurgitation: Triluminate Pivotal Trial
|
Jan 02, 2024 |
|
JACC - January 2 - 9, 2024 Issue Summary
|
Jan 02, 2024 |
|
JACC - December 19 - 26, 2023 Issue Summary: A Heart-Healthy and Stroke-Free World: Using Data to Inform Global Action
|
Dec 11, 2023 |
|
Disparities in Diagnosis, Treatment, and Outcomes of Peripheral Artery Disease: JACC Scientific Statement
|
Dec 04, 2023 |
|
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
|
Dec 04, 2023 |
|
Association of Lipoprotein(a) Levels with Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis
|
Dec 04, 2023 |
|
Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events
|
Dec 04, 2023 |
|
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in Seven Clinical Trials
|
Dec 04, 2023 |
|
JACC - December 12, 2023 Issue Summary
|
Dec 04, 2023 |
|
Comparison of Intravascular Imaging, Functional or Angiographically Guided Coronary Intervention
|
Nov 27, 2023 |
|
Neuroimaging and neurodevelopmental outcomes among individuals with complex congenital heart disease
|
Nov 27, 2023 |
|
Adjusting for Congenital Heart Surgery Risk Using Administrative Data
|
Nov 27, 2023 |
|
Systemic Atrioventricular Valve Surgery in Patients with Congenitally Corrected Transposition of the Great Vessels
|
Nov 27, 2023 |
|
Longitudinal Changes in Pulmonary Pressure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study
|
Nov 27, 2023 |
|
JACC - December 5, 2023 Issue Summary
|
Nov 27, 2023 |
|
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement
|
Nov 20, 2023 |
|
Can Machine Learning Aid the Selection of Percutaneous vs. Surgical Revascularisation?
|
Nov 20, 2023 |
|
The Mortality Burden of Untreated Aortic Stenosis
|
Nov 20, 2023 |
|
Semaglutide Effects According to Ejection Fraction in Heart Failure with Preserved Ejection Fraction and Obesity
|
Nov 20, 2023 |
|
Primary Prevention of Subclinical Atherosclerosis In Young Adults: Jacc Review Topic of the Week
|
Nov 20, 2023 |
|
Determinants of Progression And Regression of Subclinical Atherosclerosis Over Six Years
|
Nov 20, 2023 |
|
JACC - November 28, 2023 Issue Summary
|
Nov 20, 2023 |
|
Management of Adults with Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review
|
Nov 13, 2023 |
|
Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients with Non-ST-Elevation Acute Coronary Syndromes
|
Nov 13, 2023 |
|
Risk of Type B Dissection in Marfan Syndrome: The Cornell Aortic Aneurysm Registry
|
Nov 13, 2023 |
|
Sleep-Related Hypoxia, Right Ventricular Dysfunction and Survival in Group 1 Pulmonary Arterial Hypertension: PVDOMICS Study
|
Nov 13, 2023 |
|
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
|
Nov 13, 2023 |
|
JACC - November 21, 2023 Issue Summary
|
Nov 13, 2023 |
|
Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes
|
Nov 06, 2023 |
|
Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
|
Nov 06, 2023 |
|
Multi-omics analysis provides novel pathways related to progression of heart failure
|
Nov 06, 2023 |
|
Association of Age and Sex with Use of Transcatheter Aortic Valve Replacement in France
|
Nov 06, 2023 |
|
JACC - November 14, 2023 Issue Summary
|
Nov 06, 2023 |
|
Implementation of Global Hearts Hypertension Control Programs in 32 Low- and Middle-Income Countries: JACC International
|
Oct 30, 2023 |
|
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function
|
Oct 30, 2023 |
|
Efficacy of Sotagliflozin in Adults with Type 2 Diabetes In Relation to Baseline Hemoglobin A1c
|
Oct 30, 2023 |
|
Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease
|
Oct 30, 2023 |
|
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
|
Oct 30, 2023 |
|
JACC - November 7, 2023 Issue Summary
|
Oct 30, 2023 |
|
Cardiovascular Fellowship Training in Cardio-Obstetrics: JACC Review Topic of the Week
|
Oct 23, 2023 |
|
Public Out-of-hospital Cardiac Arrests in Residential Neighborhoods
|
Oct 23, 2023 |
|
Network Meta-analysis of Initial Antithrombotic Regimens after Left Atrial Appendage Occlusion
|
Oct 23, 2023 |
|
Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives
|
Oct 23, 2023 |
|
Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy
|
Oct 23, 2023 |
|
JACC - October 31, 2023 Issue Summary
|
Oct 23, 2023 |
|
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
|
Oct 16, 2023 |
|
Risk-Stratification for Hospital Mortality and Postoperative Complications in Patients with Shock undergoing Cardiac Surgery
|
Oct 16, 2023 |
|
Coronary Fractional Flow Reserve Assessment by Computerized Tomography in Patients with Type 2 Myocardial Infarction
|
Oct 16, 2023 |
|
Impact of Positron Emission Tomographic Myocardial Perfusion Imaging on Patient Selection for Revascularization
|
Oct 16, 2023 |
|
Psychosocial Characteristics of Women Presenting with Myocardial Infarction With or Without Obstructive Coronary Arteries
|
Oct 16, 2023 |
|
JACC - October 24, 2023 Issue Summary
|
Oct 16, 2023 |
|
International Consensus on Differential Diagnosis and Management of Patients with Danon Disease: JACC State-of-the-Art Review
|
Oct 09, 2023 |
|
Magnetic Resonance Spectroscopy of Brain Metabolism in Fetuses with Congenital Heart Disease
|
Oct 09, 2023 |
|
Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients with Suspected Coronary Artery Disease
|
Oct 09, 2023 |
|
10-year Cardiovascular Risk in Patients with Newly-Diagnosed Type 2 Diabetes Mellitus
|
Oct 09, 2023 |
|
Comparison of Antiplatelet Monotherapies after Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks
|
Oct 09, 2023 |
|
JACC - October 17, 2023 Issue Summary
|
Oct 09, 2023 |
|
Childhood Screening for Familial Hypercholesterolemia: JACC Review Topic of the Week
|
Oct 02, 2023 |
|
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review
|
Oct 02, 2023 |
|
Prognostic Implications of the Extent of Cardiac Damage in Patients with Fabry Disease
|
Oct 02, 2023 |
|
Outcomes of Heart Transplant Donation after Circulatory Death
|
Oct 02, 2023 |
|
Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice
|
Oct 02, 2023 |
|
Relationship of Daily Step Counts to All-Cause Mortality and Cardiovascular Events
|
Oct 02, 2023 |
|
JACC - October 10, 2023 Issue Summary
|
Oct 02, 2023 |
|
Durable Mechanical Circulatory Support: JACC Scientific Statement
|
Sep 25, 2023 |
|
Outcomes after Hybrid Palliation for Infants with Critical Left Heart Obstruction
|
Sep 25, 2023 |
|
Genetic Insights on the Relation of Vascular Risk Factors and Cervical Artery Dissection
|
Sep 25, 2023 |
|
Validation of Risk-Stratification for Cardiac Events in Pregnant Women with Valvular Heart Disease
|
Sep 25, 2023 |
|
LDL-C reduction with lipid-lowering therapy for primary prevention of major vascular events among older individuals
|
Sep 25, 2023 |
|
JACC - October 3, 2023 Issue Summary
|
Sep 25, 2023 |
|
Clinical Pathway for Coronary Atherosclerosis in Patients without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
|
Sep 18, 2023 |
|
Chronic Medication Burden after Cardiac Surgery for Pediatric Medicaid Beneficiaries
|
Sep 18, 2023 |
|
Impaired Renal Function and Major Cardiovascular Events in Young Adults
|
Sep 18, 2023 |
|
Association of High-Sensitivity Cardiac Troponin-T with 30-day and Five-year Mortality after Cardiac Surgery
|
Sep 18, 2023 |
|
Transcatheter Edge-to-Edge Repair in 5,000 Patients with Secondary Mitral Regurgitation: COAPT Post-Approval Study
|
Sep 18, 2023 |
|
JACC - September 26, 2023 Issue Summary
|
Sep 18, 2023 |
|
Comprehensive Management of Anoca, Part 2—Program Development, Treatment, And Research Initiatives: Jacc State-Of-The-Art Review
|
Sep 11, 2023 |
|
Comprehensive Management of ANOCA Part 1 – Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review
|
Sep 11, 2023 |
|
Survival after Cardiac Transplantation in Adults with Single-Ventricle Congenital Heart Disease
|
Sep 11, 2023 |
|
20-Year Experience with Repair of Pulmonary Atresia or Stenosis and Major Aortopulmonary Collateral Arteries
|
Sep 11, 2023 |
|
Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging with Cardiovascular Outcomes
|
Sep 11, 2023 |
|
Impact of Complete Revascularization in the ISCHEMIA Trial
|
Sep 11, 2023 |
|
JACC - September 19, 2023 Issue Summary
|
Sep 11, 2023 |
|
Ventricular Arrhythmias in Adults with Congenital Heart Disease Part I: JACC State-of-the-Art Review
|
Sep 04, 2023 |
|
Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis
|
Sep 04, 2023 |
|
Underutilization of Mineralocorticoid Antagonists in Patients with Heart Failure and Reduced Ejection Fraction
|
Sep 04, 2023 |
|
Cardiovascular Events after Aortic Root Repair in Patients with Marfan Syndrome
|
Sep 04, 2023 |
|
Long-term Outcome and Prognosis of Non-Infectious Thoracic Aortitis
|
Sep 04, 2023 |
|
JACC - September 12, 2023 Issue Summary
|
Sep 04, 2023 |
|
Ablation To Reduce Atrial Fibrillation Burden And Improve Outcomes: Jacc Review Topic of the Week
|
Aug 28, 2023 |
|
Efficacy of Dapagliflozin According To Geographical Location of Patients With Heart Failure
|
Aug 28, 2023 |
|
Trends in Mortality Following ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: 2003-2018
|
Aug 28, 2023 |
|
Long-term Outcomes of Cardiogenic Shock Complicating Myocardial Infarction
|
Aug 28, 2023 |
|
Temporal trends in non-cardiovascular morbidity and mortality following acute myocardial infarction: A nationwide Danish study
|
Aug 28, 2023 |
|
JACC - September 5, 2023 Issue Summary
|
Aug 28, 2023 |
|
Neighborhood Childhood Opportunity, Race/Ethnicity, and Surgical Outcomes in Children with Congenital Heart Disease
|
Aug 21, 2023 |
|
Age-Tailored Monitoring of Myocardial Involvement in Arrhythmogenic Cardiomyopathy
|
Aug 21, 2023 |
|
Predictors of Mortality with a Fully Magnetically Levitated LVAD at 5-years: A MOMENTUM-3 Trial Analysis
|
Aug 21, 2023 |
|
Prevalence, Characteristics and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients
|
Aug 21, 2023 |
|
JACC - August 29, 2023 Issue Summary
|
Aug 21, 2023 |
|
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases. JACC Guideline Comparison
|
Aug 14, 2023 |
|
Risk of Arrhythmic Death in Patients with Non-Ischemic Cardiomyopathy: JACC Review Topic of the Week
|
Aug 14, 2023 |
|
Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte and Histological Analysis
|
Aug 14, 2023 |
|
Bleeding and Ischemic Risks of Ticagrelor Monotherapy after Coronary Interventions
|
Aug 14, 2023 |
|
Cardiac Effects of Long Duration Space Flight
|
Aug 14, 2023 |
|
Return-to-Play for Elite Athletes with Genetic Heart Diseases Predisposing to Sudden Cardiac Death
|
Aug 14, 2023 |
|
JACC - August 22, 2023 Issue Summary
|
Aug 14, 2023 |
|
Transformative Impact of Geroscience On Understanding Cvd In Older Adults And Developing New Therapeutic Strategies
|
Aug 07, 2023 |
|
Low Dose Colchicine (0.5 mg daily) for the Secondary Prevention of Coronary Artery Disease
|
Aug 07, 2023 |
|
Pulmonary Artery Hypoplasia in Neonates with Tetralogy of Fallot
|
Aug 07, 2023 |
|
Fatal Cardiac Arrhythmias During Electronic Gaming In Patients With Genetically Mediated Heart Diseases
|
Aug 07, 2023 |
|
Subcutaneous Implantable Cardioverter Defibrillators in Patients with Congenital Heart Disease
|
Aug 07, 2023 |
|
First-in-Human Transapical Beating-Heart Septal Myectomy in Patients with Hypertrophic Obstructive Cardiomyopathy
|
Aug 07, 2023 |
|
JACC - August 15, 2023 Issue Summary
|
Aug 07, 2023 |
|
Bridging Treatment Implementation Gaps In Patients With Heart Failure: Jacc Focus Seminar
|
Jul 31, 2023 |
|
Management of Worsening Heart Failure With Reduced Ejection Fraction: Jacc Review Topic of the Week
|
Jul 31, 2023 |
|
Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Review Topic of the Week
|
Jul 31, 2023 |
|
GLP1 Receptor Agonist Therapy with and without SGLT2 inhibitors in Patients with Type 2 Diabetes
|
Jul 31, 2023 |
|
Prognostic Performance of Right Ventricular Global Longitudinal Strain Measurements in Patients with Ebstein Anomaly
|
Jul 31, 2023 |
|
Right Ventricular Function and Coupling to Pulmonary Circulation in Heart Failure with Preserved Ejection Fraction
|
Jul 31, 2023 |
|
High-Sensitivity Cardiac Troponin for Risk Assessment in Patients with Chronic Coronary Artery Disease
|
Jul 31, 2023 |
|
JACC - August 8, 2023 Issue Summary
|
Jul 31, 2023 |
|
Mechanisms of Aortic Dilation in Patients with Bicuspid Aortic Valve: JACC: State-of-the-Art Review
|
Jul 24, 2023 |
|
Global Comparison of Re-admission Rates for Patients with Heart Failure
|
Jul 24, 2023 |
|
C-Reactive Protein and Risk of Incident Heart Failure in Patients with Cardiovascular Disease
|
Jul 24, 2023 |
|
Combination lipid-lowering therapy in patients treated with percutaneous coronary intervention in practice: assessing RACING generalizability
|
Jul 24, 2023 |
|
Post-approval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System
|
Jul 24, 2023 |
|
JACC - August 1, 2023 Issue Summary
|
Jul 24, 2023 |
|
Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation
|
Jul 17, 2023 |
|
Role of Human Epicardial Adipose Tissue-Derived miR-92a-3p in Myocardial Redox State
|
Jul 17, 2023 |
|
Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial
|
Jul 17, 2023 |
|
Short-term Outcomes of Tricuspid Edge-to-Edge Repair in Clinical Practice
|
Jul 17, 2023 |
|
JACC - July 25, 2023 Issue Summary
|
Jul 17, 2023 |
|
Consumer Wearable Health and Fitness Technology in Cardiovascular Medicine: JACC State-of-the-Art Review
|
Jul 10, 2023 |
|
Comparison of Left Bundle-Branch Area Pacing to Biventricular Pacing in Candidates for Resynchronization Therapy
|
Jul 10, 2023 |
|
Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy
|
Jul 10, 2023 |
|
Dispatch of Volunteer Responders to Out-of-Hospital Cardiac Arrests
|
Jul 10, 2023 |
|
Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial
|
Jul 10, 2023 |
|
JACC - July 18, 2023 Issue Summary
|
Jul 10, 2023 |
|
Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week
|
Jul 03, 2023 |
|
Cardiovascular Outcomes in Patients with Diabetes and Kidney Disease: JACC Review Topic of the Week
|
Jul 03, 2023 |
|
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients with Heart Failure
|
Jul 03, 2023 |
|
Impact of Malnutrition in Patients with Heart Failure and Secondary Mitral Regurgitation: COAPT Trial
|
Jul 03, 2023 |
|
Outcomes of SAPIEN-3 Transcatheter Aortic Valve Replacement Compared with Surgical Valve Replacement in Intermediate-Risk Patients
|
Jul 03, 2023 |
|
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
|
Jul 03, 2023 |
|
JACC - July 11, 2023 Issue Summary
|
Jul 03, 2023 |
|
Long-term Outcomes of Women with Peripartum Cardiomyopathy having Subsequent Pregnancies
|
Jun 26, 2023 |
|
Angiotensin-Neprilysin Inhibition in Patients with Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
|
Jun 26, 2023 |
|
JACC - July 4, 2023 Issue Summary
|
Jun 26, 2023 |